None

None
None

Abstract

Experimental data determined at AstraZeneca on a set of compounds in the following assays: pKa, lipophilicity (LogD7.4), aqueous solubility, plasma protein binding (human, rat, dog , mouse and guinea pig), intrinsic clearance (human liver microsomes, human and rat hepatocytes). The references provided for the assays exemplify the experimental procedures used in generating the data.

Knowledge Graph

Similar Paper

None
None nan
Species differences in drug plasma protein binding
Med. Chem. Commun. 2014.0
Prediction of Volume of Distribution Values in Humans for Neutral and Basic Drugs Using Physicochemical Measurements and Plasma Protein Binding Data
Journal of Medicinal Chemistry 2002.0
Development of a simple proton nuclear magnetic resonance-based procedure to estimate the approximate distribution coefficient at physiological pH (log D 7.4 ): Evaluation and comparison to existing practices
Bioorganic & Medicinal Chemistry Letters 2017.0
Contribution of Ionization and Lipophilicity to Drug Binding to Albumin:  A Preliminary Step toward Biodistribution Prediction
Journal of Medicinal Chemistry 2004.0
Lipophilicity of acidic compounds: Impact of ion pair partitioning on drug design
Bioorganic & Medicinal Chemistry Letters 2011.0
In Silico Assay for Assessing Phospholipidosis Potential of Small Druglike Molecules: Training, Validation, and Refinement Using Several Data Sets
Journal of Medicinal Chemistry 2012.0
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure
Journal of Pharmaceutical Sciences 2005.0
Ionization and lipophilicity in nonpolar media mimicking the cell membrane interior
Bioorganic & Medicinal Chemistry 2023.0
ElogD<sub>o</sub><sub>ct</sub>:  A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds
Journal of Medicinal Chemistry 2001.0